Yao Pharma's deal with the US pharmaceutical giant underscores China's growing role in global biotech licensing US ...
The deal will help Pfizer beef up and diversify its obesity drug pipeline following its $10 billion acquisition of obesity ...
A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial ...
Obesity China's sixth leading risk factor in disability, death Number of overweight, obese to increase to 65% by 2030 Weight-loss drugs too expensive, doctors say Generics could bring price pressure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback